NTLA Stock Analysis: Buy, Sell, or Hold?
NTLA - Intellia Therapeutics, Inc
$10.68
-0.41 (-3.70%)
▼
5d:
-0.47%
30d:
-38.05%
90d:
-20.77%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
3d
Smart Money Accumulation
None View Scanner →
Strength: 4.9/10
Get Alerted When NTLA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NTLA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NTLA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NTLA is currently trading at $10.68, which is considered oversold relative to its 30-day fair value range of $11.21 to $16.47.
Technical Outlook: Technically, NTLA is showing sideways momentum. Immediate support is located at $10.15, while resistance sits at $11.66. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: NTLA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $26.17 (+145.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NTLA is showing sideways momentum. Immediate support is located at $10.15, while resistance sits at $11.66. Short-term momentum is weak, with the stock down 3.7% recently.
Market Sentiment: NTLA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $26.17 (+145.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$11.21 -
$16.47
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding NTLA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.7%)
- BULLISH: Trading 145.0% below Wall St target ($26.17)
Trading Range Analysis
30-Day Trading Range
$11.21 -
$16.47
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$10.15
Resistance Level
$11.66
Current Trend
Sideways
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.07
Wall Street Target
$26.17
(+145.0%)
Revenue Growth (YoY)
-9.5%
Share & Embed Analysis
Last updated: August 02, 2026 2:48 PM ET
Data refreshes hourly during market hours. Next update: 3:48 PM
Data refreshes hourly during market hours. Next update: 3:48 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTLA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 60 HOLD |
Advanced NTLA Option Strategies
Professional options setups generated by AI based on today's NTLA price and gamma walls.
